OTCM
RAFLF
Market cap1.18bUSD
, Last price
Name
Raffles Medical Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Raffles Medical Group Ltd (RMG), a prominent Singapore-headquartered company, delivers integrated private healthcare services across Singapore, Greater China, Vietnam, Cambodia, and Japan. Its operations are structured into Healthcare Services, Hospital Services, and Investment Holdings segments. The group's flagship institution, Raffles Hospital, functions as a tertiary care facility, offering a broad spectrum of medical services. These include oncology, pediatrics and women's health, traditional Chinese medicine, counseling, dental care, dialysis, diabetes and endocrinology, ENT, ophthalmology, fertility treatments, cardiology, internal medicine, neuroscience, pain management, rehabilitation, orthopedics, dermatological and aesthetic services, general surgery, nuclear medicine, and urology. Beyond the hospital, RMG provides emergency services, family medicine, comprehensive health screening, and a variety of multi-disciplinary specialist clinic services. Additionally, the company engages in the trade of pharmaceutical and nutraceutical products, and diagnostic equipment. It also offers advisory and consultancy services, develops IT solutions, and undertakes research and experimental development in biotechnology, life sciences, and medical science. The company was founded in 1976.
Key people
Choon Yong Loo
Non-Independent Executive Chairman of the Board · since 1997
Yeng Yeng Woo
Chief Financial Officer · since 2025
Kah Ling Teo
Chief Information Officer · since 2017
Tien Beng Phua
Deputy Managing Director - Raffles China Healthcare · since 2025
Ben Siah
General Manager - Raffles Health Insurance · since 2024
Hsiang Lung Tan
General Manager - Raffles Hospital · since 2021
Clark Cheng
Deputy General Manager - Singapore Healthcare Raffles Wellness · since 2024
Joo Peng Tan
Deputy General Manager - Singapore Healthcare · since 2024
Sarah Lu Qinghui
Executive Medical Director - Raffles Physicians, Non-Independent Executive Director · since 2024
Shih Kiat Chng
Executive Medical Director - Raffles Medical
Anthony Foo
Deputy Medical Director - Raffles Hospital Singapore · since 2021
Nora Heng
Deputy Dental Director - Raffles Dental Singapore · since 2024
Nandha Kumar
Deputy Medical Director - Raffles Medical Singapore
I Wuen Lee
Medical Director - Raffles Hospital Singapore · since 2021
Isaac Liu
Deputy Medical Director - Raffles Hospital Singapore · since 2021
Alfred Loh
Senior Clinical Director - Raffles Medical Singapore
Salleh Omar
Deputy Medical Director - Raffles Medical Singapore
Yoichi Onishi
Medical Director - Raffles Japanese Clinic
Charles Poon
Medical Director - Raffles Hospital, Beijing · since 2020
Walter Tan
Medical Director - Raffles Hospital Singapore
IPO date
Apr 11, 1997
Employees
2,800
Domiciled in
SG
Incorporated in
SG
Legal address
585 North Bridge Road
#11-00
Raffles Hospital
Singapore, 01 188770
SG
#11-00
Raffles Hospital
Singapore, 01 188770
SG
Headquarters
585 North Bridge Road
#22-00
Raffles Specialist Centre
Singapore, 01 188770
SG
#22-00
Raffles Specialist Centre
Singapore, 01 188770
SG
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||